- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/04 - Cyclic or bridged peptides or polypeptides, e.g. bacitracin
Patent holdings for IPC class C12P 21/04
Total number of patents in this class: 957
10-year publication summary
60
|
22
|
30
|
29
|
25
|
16
|
8
|
11
|
5
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Trustees of the University of Pennsylvania | 4314 |
11 |
Abbvie Inc. | 1800 |
11 |
California Institute of Technology | 3973 |
9 |
Novozymes A/S | 3320 |
9 |
Codexis, Inc. | 798 |
9 |
Regeneron Pharmaceuticals, Inc. | 4242 |
9 |
Novartis AG | 10886 |
8 |
The Regents of the University of California | 19857 |
8 |
Ajinomoto Co., Inc. | 2304 |
8 |
Bunge Oils, Inc. | 121 |
8 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 67 |
8 |
The University of Tokyo | 4168 |
8 |
Genentech, Inc. | 3979 |
7 |
Ambrx, Inc. | 181 |
7 |
Centocor, Inc. | 58 |
7 |
CJ Cheiljedang Corporation | 3407 |
7 |
Gevo, Inc. | 258 |
7 |
Allergan, Inc. | 2356 |
6 |
President and Fellows of Harvard College | 5964 |
6 |
University of Florida Research Foundation, Inc. | 4002 |
6 |
Other owners | 798 |